Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Not authorised
- Retinol palmitate
- COLECALCIFEROL CONCENTRATE (OILY FORM)
- DL-ALPHA TOCOPHEROL ACETATE
Product identification
Medicine name:
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Belavit AD3E, raztopina za injiciranje za konje, govedo, prašiče in pse
Active substance:
- Retinol palmitate
- COLECALCIFEROL CONCENTRATE (OILY FORM)
- DL-ALPHA TOCOPHEROL ACETATE
Target species:
-
Cattle
-
Dog
-
Horse
-
Pig
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Retinol palmitate176.46/milligram(s)1.00millilitre(s)
-
COLECALCIFEROL CONCENTRATE (OILY FORM)100.00/milligram(s)1.00millilitre(s)
-
DL-ALPHA TOCOPHEROL ACETATE50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Milk120hour
-
Meat and offal259day
-
-
Horse
-
Meat and offal250day
-
Milkno withdrawal periodNot authorised for use in horses producing milk for human consumption.
-
-
Pig
-
Meat and offal194day
-
-
-
Intramuscular use
-
Cattle
-
Milk120hour
-
Meat and offal259day
-
-
Horse
-
Meat and offal250day
-
Milkno withdrawal periodNot authorised for use in horses producing milk for human consumption.
-
-
Pig
-
Meat and offal194day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA11JA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Slovenia
Package description:
- (ID3): 1 unspecified outer container with 12 Bottle (Glass) with 100 millilitre(s) (1200 millilitre(s))
- (ID2): 1 unspecified outer container with 6 Bottle (Glass) with 100 millilitre(s) (600 millilitre(s))
- (ID1): 1 unspecified outer container with 1 Bottle (Glass) with 100 millilitre(s) (100 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- MR/V/0668/001
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0313/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 14/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 14/02/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 14/02/2022
Combined File of all Documents
English (PDF)
Download Published on: 15/02/2022